John Weiland

John H.
Weiland is Director & Vice President at Rochester Medical Corp.
since 2013.
He is Director at Receptos LLC since 2018.
He serves as Director at The Horatio Alger Association of Distinguished Americans.
He is Independent Director at Solventum Corp.
starting in 2024.
Formerly, Mr. Weiland was President & Chief Executive Officer at Pharmacia AB and Alfa Wassermann, Inc. He was Vice Chairman, President & Chief Operating Officer at C.
R.
Bard, Inc. (New Jersey) from 2016 to 2017.
He served as Independent Director at Cardinal Health, Inc. from 2019 to 2022, at Celgene Corp.
from 2018 to 2019, and at West Pharmaceutical Services, Inc. from 2007 to 2019.
He was Director & Vice President at Liberator Medical Holdings, Inc. and Liberator Medical Supply, Inc. He was Director at SenoRx, Inc. and Meridian Health System, Inc. He was Vice President-Eastern United States at Baxter International, Inc. from 1988 to 1989.
He was Principal at American Hospital Supply Corp.
He was Trustee at DeSales University.
He was Senior Vice President-North America at DENTSPLY International, Inc. from 1991 to 1996.
Education includes an undergraduate degree from DeSales University in 1977 and an MBA from New York University in 1987.